Group One Trading’s Neos Therapeutics, Inc NEOS Stock Holding History

Group One Trading’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,500	Closed	-$7K	–	8266
2020 Q4	$7K	Buy	+10,500	New	+$6.49K	﹤0.01%	5945
2018 Q2	–	Sell	-11,100	Closed	-$92K	–	5658
2018 Q1	$92K	Sell	11,100 -37,300	-77%	-$356K	﹤0.01%	3300
2017 Q4	$494K	Buy	48,400 +9,300	+24%	+$89.2K	﹤0.01%	2266
2017 Q3	$358K	Sell	39,100 -1,500	-4%	-$11.4K	﹤0.01%	2341
2017 Q2	$296K	Buy	+40,600	New	+$307K	﹤0.01%	2358

Group One Trading's NEOS Position: Q1 2021 in Review

Group One Trading sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 8,605 shares — an estimated $5K sold.

Group One Trading first reported a position in NEOS in Q2 2017 and held it in 15 quarters. The position peaked at $683K in Q4 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.

Group One Trading reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
Group One Trading sold 8,605 Neos Therapeutics, Inc shares in Q1 2021, an estimated $5K.
Group One Trading first reported a position in Neos Therapeutics, Inc in Q2 2017 and held it in 15 quarters.
Group One Trading's Neos Therapeutics, Inc position peaked at $683K in Q4 2017.
0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.

Based on Group One Trading's 13F filing for Q1 2021, filed 12 May 2021.